Investing.com
META stock: Analyst frames bull vs. bear debate into the New Year
📊
AI Sentiment
Positive
7/10
Parcl USD News
Latest updates and market news for PRCL-USD
20 news
Dec 18 - Dec 24, 2025
Page 1
PR Newswire
Historic $15 Million Gift Fuels Breakthrough Cancer Care at Hartford HealthCare St. Vincent's Medical Center
📈
AI Sentiment
Highly Positive
9/10
The Wall Street Journal
Oil Futures Slip With Venezuela, Russia-Ukraine in Focus
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Third-Quarter Economic Growth at 2-Year High Amid Consumer Spending Boost
📈
AI Sentiment
Highly Positive
9/10
The Duncan Banner, Okla.
Duncan receives clean audit report for 2024
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Home Genius Exteriors Expands Executive Leadership Team with Appointment of Suraj Akotia
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER
📈
AI Sentiment
Highly Positive
9/10
Yahoo Finance Video
Bitcoin: A look back at the crypto asset's wild ride in 2025
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Hycroft Mining's Drilling Program Confirms Continuity of High-Grade Silver at Nevada Mine
âž–
AI Sentiment
Neutral
5/10
decrypt
Bitcoin Hits $90,000—But Rally May Not Last Through Holidays
âž–
AI Sentiment
Neutral
4/10
GlobeNewswire
Wearable AI Industry Sizing and Opportunity Outlook 2025-2030 Featuring Apple, BRAGI, OrCam Technologies, Polar Electro, RealWear, Nexxbase Marketing, ThirdEye Gen, Everysight and Other Key Players
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Transactions in connection with share buyback programme
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58
📊
AI Sentiment
Positive
7/10
Insider Monkey
TD Cowen Reduces PT on Vital Farms (VITL) to $44 From $59
Insider Monkey
Is Five9, Inc. (FIVN) One of the Best Small Cap Stocks to Buy With Huge Upside Potential?
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Wells Fargo Reaffirms a Buy Rating on Nurix Therapeutics (NRIX), Sets a $30 PT
📈
AI Sentiment
Highly Positive
8/10
Share this news page